Direct (non-chromatographic) quantification of drugs and their metabolites from human plasma utilizing chemical lonization mass spectrometry and stable isotope labeling: Quinidine and lidocaine
- 1 April 1974
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 1 (2) , 124-129
- https://doi.org/10.1002/bms.1200010208
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Method for the measurement of prostaglandin F2.alpha. in biological fluids by gas chromatography-mass spectrometryAnalytical Chemistry, 1973
- Quantitative determination of carbamazepine in plasma by mass fragmentographyClinical Pharmacology & Therapeutics, 1973
- Applications of Integrated Gas Chromatography/Mass Spectrometry in Pharmacology and ToxicologyAnnual Review of Pharmacology, 1973
- Deuterium substituted amphetamine as an internal standard in a gas chromatographic/mass spectrometric (GC/MS) assay for amphetamineAnalytical Chemistry, 1973
- Use of stable isotopes in pharmacology‐clinical pharmacologyClinical Pharmacology & Therapeutics, 1972
- Identification of dangerous drugs by isobutane chemical ionization mass spectrometryAnalytical Chemistry, 1971
- Novel peak matching technique by means of a new and combined multiple ion detector-peak matcher device. Elemental analyses of compounds in submicrogram quantities without prior isolationAnalytical Chemistry, 1971
- Pharmacokinetics of lidocaine in manClinical Pharmacology & Therapeutics, 1971
- Chemical ionization mass spectrometry of complex molecules. II. AlkaloidsJournal of the American Chemical Society, 1970
- Mass fragmentographyAnalytical Biochemistry, 1968